1. Design and Analysis of Bioavailability and Bioequivalence Studies
2. FDA(1992).Guidance on Statistical Procedures for Bioequivalence Studies Using a Standard Two‐Treatment Crossover Design. Division of Bioequivalence Office of Generic Drugs Food and Drug Administration Rockville MD July 1.
3. FDA(2003).Guidance on Bioavailability and Bioequivalence Studies for Orally Administered Drug Products – General Considerations. Center for Drug Evaluation and Research Food and Drug Administration Rockville MD.
4. Pharmacokinetics